Dear Reader,

The interactive, discussion and Q&A segments of last year’s programme were so successful we have made sure that this November, the World Biosimilar Congress delivers on that once again.

Put across your perspective, debate the controversies and ask those pertinent questions that will enable you to take your biosimilar operations forward towards 2020, in a series of panels across the 2 days of the Congress:

Panel: Pricing Debate

Are biosimilars cost effective?
What economic aspects need to be reviewed when it comes to biosimilars versus reference biologics?
Lessons learnt from existing biosimilar approvals, both in the EU and the USA as well as in emerging markets, especially in terms of pricing and sustainability of the market

Featuring:

Asbjorn Mack, Health Economic Advisor, Norwegian Health Procurement
Adam Kautzner, Vice President, Formulary & Drug Trends Solutions, Express Scripts

Panel: The ‘Indication Extrapolation Conundrum’

Following the USA’s first biosimilar approval, what do we know about international practices regarding extrapolation?
How can biosimilar developers best approach this challenge given different regulators are reviewing data differently, with different views on what is clinically meaningful?

Featuring:

Cecil Nick, Vice President, PAREXEL
Jorge Santos da Silva, Principal, McKinsey & Co
Bernd Liedert, Sr.Clinical Program Leader Biosimilars, Boehringer Ingelheim

Panel: What are the mechanics required behind the implementation of biosimilars in the market?

How important is post-market surveillance to implementing biosimilars in the market in the first place?
How has USA’s first biosimilar approval contributed to the debate on naming? What can we expect to see with this ongoing debate as we move closer to 2020?

Featuring:

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines
Kim Greco, Director, Research and Development Policy, Amgen
Pierre Michetti, Gastroenterologist, Centre Hospitalier Universitaire Vaudois

Click here to register and be a part of the discussion.

*Register before Friday 7th October and save €230!*

All the best,

Jessica Robinson

Conference Manager, World Biosimilar Congress 2016

t/ +44 (0)207 092 1150

e/ Jessica.robinson@terrapinn.com

P.S- Need more information? Download the brochure here